Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 184   

Articles published

AZN 4,583.57 +6.07 (0.13%)
price chart
Big Director Buys At AstraZeneca plc, Royal Mail PLC And Saga PLC
AstraZeneca In these days of summer sales and sails, directors at AstraZeneca (LSE: AZN) (NYSE: AZN.US), Royal Mail (LSE: RMG) and Saga (LSE: SAGA) have been buying shares in their own companies.
AstraZeneca plc Shares Gap Up After Dividend Announcement (AZN)  WKRB News
Drug Stocks Edged Up: GlaxoSmithKline plc (NYSE:GSK), AstraZeneca PLC ...  WallStreet Scope
Related articles »  
The FTSE 100′s Hottest Dividend Picks: AstraZeneca Plc
AstraZeneca A backdrop of heavy earnings pressure in recent has forced pharma giant AstraZeneca to put the skids on progressive payouts in recent times.
AstraZeneca And Pfizer Can Commence Merger Talks Again
Investors continue to invest in AstraZeneca plc's (AZN) stock on hopes that the company will come to the table to discuss merging with Pfizer Inc. (PFE) once the mandatory three-month cooling period ends.
UK Stocks Rise as AstraZeneca Gains on Pfizer Report  Businessweek
AstraZeneca rises as investors bet on revival of Pfizer deal
Related articles »  
Will The US Block Shire PLC's Buyout And Prevent A Takeover Of AstraZeneca ...
When it was announced, investors celebrated the announcement that US pharmaceutical giant, AbbVie was making a �32bn takeover offer for Shire (LSE: SHP) (NASDAQ: SHPG.
AstraZeneca plc Given "Hold" Rating at Deutsche Bank (AZN)
Deutsche Bank reiterated their hold rating on shares of AstraZeneca plc (LON:AZN) in a research report sent to investors on Thursday morning.
Beaufort Securities Reiterates Hold Rating for AstraZeneca plc (AZN)  Mideast Time
AstraZeneca plc Given �Hold� Rating at Panmure Gordon (AZN)  Ticker Report
Related articles »  
AstraZeneca plc Target of Unusually High Options Trading (AZN)
AstraZeneca plc logo AstraZeneca plc (NYSE:AZN) was the recipient of some unusual options trading activity on Thursday.
AstraZeneca plc Receives Average Recommendation of �Hold� from Brokerages ...  Intercooler
AstraZeneca plc's �Hold� Rating Reaffirmed at Deutsche Bank (AZN)  sleekmoney
Related articles »  
Bryan Garnier & Cie Reaffirms Neutral Rating for AstraZeneca plc (AZN)
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its �neutral� rating restated by equities researchers at Bryan Garnier & Cie in a research report issued on Thursday.
AstraZeneca plc Rating Reiterated by Bryan Garnier & Cie (AZN)  sleekmoney
Related articles »  
AstraZeneca plc Stock Rating Reaffirmed by Panmure Gordon (AZN)
Shares of AstraZeneca plc (LON:AZN) opened at 4436.50 on Friday. AstraZeneca plc has a one year low of GBX 3086.50 and a one year high of GBX 5750.00.
Deutsche Bank Reiterates Hold Rating for AstraZeneca plc (AZN)  Ticker Report
Jefferies Group Reaffirms Hold Rating for AstraZeneca plc (AZN)  Intercooler
Related articles »  
AstraZeneca plc Price Target Raised to GBX 4000 at Deutsche Bank (AZN)
AstraZeneca plc (LON:AZN) had its price target upped by Deutsche Bank from GBX 3,950 ($66.46) to GBX 4,000 ($67.31) in a research note issued to investors on Friday.
AstraZeneca plc Given Underweight Rating at JPMorgan Chase & Co. (AZN)  Ticker Report
AstraZeneca plc Receives "Equal Weight" Rating from Barclays (AZN)  Watch List News (press release)
Related articles »  
Why AstraZeneca (AZN) Stock Is Higher Today
NEW YORK (TheStreet) -- Shares of AstraZeneca PLC (AZN) are higher by 1.98% to $75.71 in mid-morning trading on Friday, as speculation stirs suggesting Pfizer Inc. (PFE) might resume takeover discussions, the Wall Street Journal reports.